Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals
Liquids · 20.11.2023 · 3 (4) · 456-468
DOI: 10.3390/liquids3040029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liquids, online erschienen am 20.11.2023. Verfasst von Linh Dinh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45229, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Lyotropic liquid crystals (LLCs) are liquids that have crystalline structures. LLCs as drug delivery systems that can deliver hydrophobic, hydrophilic, and amphiphilic agents. Due to their unique phases and structures, LLCs can protect both small molecules and biologics from the gastrointestinal tract’s harsh environment, thus making LLCs attractive as carriers for oral drug delivery. In this review, we discuss the advantages of LLCs and LLCs as oral formulations targeting intestinal lymphatic transport. In oral LLC formulations, the relationship between the micelle compositions and the resulting LLC structures as well as intestinal transport and absorption were determined. In addition, we further demonstrated approaches for the enhancement of intestinal lymphatic transport: (1) lipid-based LLCs promoting chylomicron secretion and (2) the design of LLC nanoparticles with M cell-triggered ligands for targeting the M cell pathway. In this review, we introduce LLC drug delivery systems and their characteristics. Our review focuses on recent approaches using oral LLC drug delivery strategies targeting the intestinal lymphatic system to enhance drug bioavailability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45229, USA.
Förderung
- NIAAA NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Dinh, L., & Yan, B. (2023). Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals. Liquids, 3(4), 456-468. https://doi.org/10.3390/liquids3040029
Vancouver
Dinh L, Yan B. Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals. Liquids. 2023;3(4):456-468. doi:10.3390/liquids3040029
BibTeX
@article{Dinh2023,
author = {Dinh, Linh and Yan, Bingfang},
title = {Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals},
journal = {Liquids},
year = {2023},
volume = {3},
number = {4},
pages = {456--468},
doi = {10.3390/liquids3040029}
}
EUVIMED